Jump to content or navigation.
Eranid Coordination of Research on illicit drugs Contact us

Searching information on drug research projects

This database contains information gathered in the course of the ERANID project during 2013 and 2014. Principally, it contains details of research projects on illicit drugs carried out since 2010 within the six ERANID countries and funded by the European Committee: Belgium; France; Italy; Portugal; The Netherlands; and the United Kingdom. However, this database will not capture all illicit drugs research carried out within a country.

90 projects matched the selected criteria:

Download as PDFDownload as PDF

Study of psychopathological and addictive profile of patients suffering from Buerger's disease

ETUDE DU PROFIL PSYCHOPATHOLOGIQUE ET ADDICTOLOGIQUE DE PATIENTS ATTEINTS DE MALADIE DE BUERGER
Funding country
France
Project starting year
2009
Project ending year
2016
Area(s) of research
Prevalence, incidence and patterns of drug use, Prevention responses, Treatment responses
Objectives
What are the factors limiting abstinence from tobacco and cannabis use
Scientific discipline(s) involved
History, Neurosciences, Psychology, Other medical sciences, Psychiatry, Addictology
Read more…
Objectives (native)
Quels sont les facteurs de limitation à l'arrêt de l'intoxication au tabac et au cannabis
Initial identified needs
Compromised prognosis for survival of young patients with arterial disease addicted to tobacco and cannabis
Initial identified needs (native)
Mise en jeu du pronostic vital de patients artétitiques jeunes dépendants au tabac et au cannabis
Performed by
CHRU (Regional University Hospital) of Lille
HEGP APHP PARIS
CHU de BREST
CHU de TOURS
CHU de BORDEAUX, CHU de MONTPELLIER, CHU de NANCY, CHU de TOULOUSE, CHU de STRASBOURG, CHU de MARSEILLE, CHU de CAEN, CH de VALENCIENNES
Funded by
PHRC
Summary references
Website
Published reference(s)
Download as PDFDownload as PDF

The Coquelicot Survey- Seroprevalence of HIV and HCV in drug users in France and dertermining factors of the at riskpractices

Enquête Coquelicot - Séroprévalence du VIH et du VHC chez les usagers de drogues en France et déterminants des pratiques à risque
Funding country
France
Project starting year
2010
Project ending year
2016
Area(s) of research
Prevalence, incidence and patterns of drug use, Harm reduction responses, Consequences of drug use, Methodology issues
Objectives
To estimate the HIV and HCV prevalences among drug users (DU) in France. To compare the biological data to the declarative data. To implement a poll scheme including the Generalized weight share method ( MGPP) to improve the estimations. To describe the at risk situations related to drug use and sexual behaviour with regard to the transmission of HIV and hepatitis and to identify their determining factors. To describe the Du's sociodemographic characteristics. To specify their perceptions and knowledge about AIDS and hepatitis. To set up a collaboration between social sciences and epidemiology in order to achieve a finer understanding of the social and relational context of risk-takings. To estimate the seroincidence of HIV and VHC within DUs. To map the genotypes of VHC among DU. To characterize the circulating virus strains of HIV among Dus and to look for possible " clusters " of transmission. To estimate the seroprevalence of HBs Antigen among DUs.
Scientific discipline(s) involved
History, Sociology
Read more…
Objectives (native)
- Estimer les séroprévalences du VIH et du VHC dans la population des UD en France. - Comparer les données biologiques et les données déclaratives. - Mettre en œuvre un plan de sondage incluant la Méthode Généralisée du Partage des Poids (MGPP) afin d’améliorer les estimations. - Décrire les situations à risque liées à la consommation de drogues et aux comportements sexuels vis-à-vis de la transmission du VIH et des hépatites et en identifier les déterminants. - Décrire les caractéristiques socio-démographiques des UD. - Préciser leurs perceptions et leurs connaissances vis-à-vis du sida et des hépatites. - Mettre en place une collaboration entre sciences sociales et épidémiologie afin d’accéder à une compréhension plus fine du contexte social et relationnel des prises de risque. - Estimer la séroincidence du VIH et VHC dans la population des UD. - Etablir une cartographie des génotypes du VHC du chez les UD. - Caractériser les souches circulantes du VIH dans la population des UD et rechercher d’éventuels « clusters » de transmission. - Estimer la séroprévalence de l’Antigène HBs dans la population des UD.
Initial identified needs
Need of reliable data on the epidemiological situation of the drug users in France data on HIV and CHV seroprevalence), so as to adapt the risk reduction politicies
Initial identified needs (native)
Nécessité de disposer de données fiables sur la situation épidémiologique des usagers de drogues en France (données de séroprévalence du VIH et du VHC), afin d'adapter la politique de réduction des risques.
Performed by
InVS
Inserm U988 (Cermes3)
Funded by
ANRS, InVS
Summary references
Jauffret-Roustide M, Le Strat Y., Couturier E, Thierry D, Rondy M, Quaglia M, et al. A national cross-sectional study among drug-users in France: epidemiology of HCV and highlight on practical and statistical aspects of the design. BMC Infect Dis 2009; 9:113-125.
Website
Published reference(s)
Download as PDFDownload as PDF

Cohort Health and Mortality among drug users addressing addiction treatment and low threshold centres

Funding country
France
Project starting year
2009
Project ending year
2017
Area(s) of research
Consequences of drug use
Objectives
To better know and to measure health problems faced by the drug users seen in specialised treatment or low threshold services, particularly with regard to death risks (collected data being strictly confidential) To better know the associated factors to the death risks To contribute to prevent those risks, thanks to the acquired knowledge, then to decrease the prevalence of deaths.
Scientific discipline(s) involved
History
Read more…
Objectives (native)
- to better know and to measure health problems faced by the drug users seen in specialised treatment or low threshold services, particularly with regard to death risks (collected data being strictly confidential) - to better know the associated factors to the death risks - to contribute to prevent those risks, thanks to the acquired knowledge, then to decrease the prevalence of deaths.
Initial identified needs
Improving the measure of the mortality related to drug uses in France has become a priority for the French Monitoring Centre on Drugs and Drug Addictions (OFDT), for several reasons. Firstly, the rate of lethal narcotic overdoses is one of the five key indicators to be reported to the European Monitoring Centre for Drugs and Drug addiction (EMCDDA), which encourages the implementation of cohort studies of drug users. In addition, the 2008-2011 French governmental drug action plan sets as a priority the reduction of the overdose related deaths. Finally, although it is an issue of great concern to public health authorities, there is still a limited knowledge of the number and the nature of these deaths in France. This cohort study require the collaboration of the French National institute for statistics and economic studies (INSEE) reporting on the vital status, the Centre for epidemiology of the medical causes of death (CepiDC) and the National institute for health and medical research (INSERM-U472) for the database linkage.
Performed by
OFDT (French Monitoring Centre on Drugs and Drug Addictions) - Unit of Indicators
INSERM (National institute for health and medical research)-U472
CepiDC (Centre for epidemiology of the medical causes of death)
INSEE (French National institute for statistics and economic studies)
Funded by
OFDT (French Monitoring Centre on Drugs and Drug Addictions)
Summary references
http://www.ofdt.fr/ofdtdev/live/reserve/cohorte2009.html
Website
http://www.ofdt.fr/ofdtdev/live/reserve/cohorte2009.html
Published reference(s)
Download as PDFDownload as PDF

QUIT-COC. Can the failures or the success of the hospital cocaine withdrawal be be predicted?

Les échecs ou les réussites du sevrage hospitalier de cocaïne peuvent-ils être prédits?(QUIT-COC)
Funding country
France
Project starting year
2014
Project ending year
2017
Area(s) of research
Treatment responses, Consequences of drug use, Mechanism of drug use and effects
Objectives
To describe the lesions through brain imaging, the clinical and neuropsychological factors associated to the relapses after hospital cocaine withdrawal.
Scientific discipline(s) involved
History, Neurosciences, Psychology
Read more…
Objectives (native)
Décrire les lésions en imagerie cérébrale, les facteurs cliniques et neuropsychologiques associés aux rechutes après sevrage hopsitalier de cocaïne.
Initial identified needs
Frequency of the relapses after the cocaine withdrawal from addiected fellows.
Initial identified needs (native)
Fréquence des rechutes après sevrage de cocaïne des sujets dépendants
Performed by
ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS
INSERM
CNRS
UNIVERSITE PARIS DESCARTES
UNIVERSITE PARIS DIDEROT ; PRES SORBONNE PARIS CITE
Funded by
MINISTERE DE LA SANTE (PHRC NATIONAL 20102)
Summary references
NON PAS ENCORE
Website
NON PAS ENCORE
Published reference(s)
Download as PDFDownload as PDF

The effect of Opiate Integrated Treatment including Methadone and Buprenorphine /Naloxone (Suboxone®) Maintenance Treatment for Injecting Drug Users at community in Ho Chi Minh City, Viet Nam

Funding country
France
Project starting year
2012
Project ending year
2017
Area(s) of research
Prevention responses, Treatment responses, Harm reduction responses, Determinants of drug use, Consequences of drug use, Mechanism of drug use and effects, Supply and markets, Methodology issues
Objectives
To adapt to the Vietnam context the methods of effective treatments of opiate related addiction that have been validated in Europe and North America.
Scientific discipline(s) involved
Anthropology, History, Psychology, Sociology, Other medical sciences, Addictology
Read more…
Objectives (native)
Adapter au contexte du Vietnam, les modalités de traitements efficaces de la dépendance aux opiacés validés en Europe et en Amérique du Nord.
Initial identified needs
To increase the access to opiate addiction treatment and make addiction treatment more accessible in Vietnam
Initial identified needs (native)
Augmenter l'accès aux soins de la toxicomanie opiacés et rendre accessible les traitements de la dépendance aux opiacés au Vietnam
Performed by
Phénoménologie et déterminants des comportements appétitifs, addictologie et psychiatrie / Sanpsy CNRS USR 3413
GIP ESTHER, Paris, France
University of Pennsylvania, Philadelphie, USA
Funded by
NIDA, ANRS
Summary references
Website
Published reference(s)
Download as PDFDownload as PDF

Neurochemical memory: what are the cellular and molecular mechanisms of its origin? Is it a factor of vulnerability to relapse?

Mémoire neurochimique : quels sont les mécanismes cellulaires et moléculaires à son origine ? Est-ce un facteur de vulnérabilité à la rechute ?
Funding country
France
Project starting year
2010
Project ending year
2018
Area(s) of research
Treatment responses, Consequences of drug use, Mechanism of drug use and effects
Objectives
Results obtained in recent years have shown in particular that the repeated injection of drugs (morphine and cocaine) is capable of leaving a "neurochemical memory" that can persist over time at least 14 days after treatment discontinuation. To summarise, we have in fact demonstrated: 1) An increase of enkephalin and dopamine in the nucleus accumbens when animals are placed in an environment where they used to receive morphine. 2) An increase of dopamine in the nucleus accumbens, and of BDNF at peripheral levels and in the nucleus accumbens, both seen specifically at the time of cocaine injection. Taken together, these results raise several questions and objectives are: 1) Is the "neurochemical memory", in respect to neurotransmitter released at the time of injection, specific to drugs, or more widely linked with an associative memory? 2) What are the molecular and cellular mechanisms behind this neurochemical memory? 3) What is the role of this neurochemical memory in the vulnerability to relapse?
Scientific discipline(s) involved
Neurosciences, Pharmacology
Read more…
Objectives (native)
L'ensemble des résultats que nous avons obtenus au cours des dernières années nous montre en particulier que l'injection répétée de drogue (morphine et cocaïne) est capable de laisser une « mémoire neurochimique » qui peut perdurer dans le temps au moins 14 jours après arrêt du traitement. Pour résumer, nous avons en effet mis en évidence : 1) Une augmentation d'enképhalines et de dopamine dans le noyau accumbens quand les animaux sont replacés dans un environnement où ils avaient l'habitude de recevoir de la morphine. 2) Une augmentation de dopamine dans le noyau accumbens, et de BDNF au niveau périphérique et dans le noyau accumbens observables spécifiquement à l'heure d'injection de la cocaïne. L'ensemble de ces résultats soulève plusieurs questions, et les objectifs sont donc: 1) La « mémoire neurochimique » en terme de libération de neurotransmetteurs à l'heure d'injection est-elle spécifique des drogues, où plus largement liée à une mémoire associative ? 2) quels sont les mécanismes moléculaires et cellulaires à l'origine de cette mémoire neurochimique? 3) Quel est le rôle de cette mémoire neurochimique dans la vulnérabilité aux rechutes ?
Initial identified needs
One of the main problems in the treatment of addiction is the high rate of relapse in drug use. Therefore, addiction requires long-term treatment. However, retention rate of patients in programmes after 6 months is low. In addition, despite the patient-reported general satisfaction with treatment many of them expressed a strong desire to be able to stop these treatments. To assist the patient in this process, it is crucial to identify those at high risk of relapse to better tailor therapeutic strategies, moving progressively towards abstinence. For this we need to better understand the neurobiology of relapse, and vulnerability factors associated with it.
Initial identified needs (native)
L'un des principaux problèmes dans le traitement de la dépendance est le taux élevé de rechute de la consommation de drogues. Par conséquent, la toxicomanie nécessite un traitement à long terme. Toutefois, le maintien des patients dans les programmes à 6 mois est faible. En outre, en dépit de la satisfaction générale aux traitements rapportés par les patients beaucoup d'entre eux expriment une forte envie de pouvoir arrêter ces traitements. Afin d'aider le patient dans cette démarche, il est crucial d'identifier ceux présentant un risque élevé de rechute afin de mieux adapter les stratégies thérapeutiques, en allant progressivement vers l'arrêt. Pour cela nous devons mieux comprendre la neurobiologie de la rechute, et les facteurs de vulnérabilité qui y sont liés.
Performed by
CNRS - Neuroplasticité et traitements des addictions
Funded by
CNRS
Summary references
Website
non
Published reference(s)
Nieto MM, Wilson J, Cupo A, Roques BP, Noble F (2002) Chronic morphine treatment modulates the extracellular levels of endogenous enkephalins in rat brain structures involved in opiate dependence: a microdialysis study. J Neurosci. 22(3):1034-41. Benturquia N, Le Marec T, Scherrmann JM, Noble F (2008) Effects of nitrous oxide on dopamine release in the rat nucleus accumbens and expectation of reward. Neuroscience. 13;155(2):341-4. Puig S, Noble F, Benturquia N (2012) Short- and long-lasting behavioral and neurochemical adaptations: relationship with patterns of cocaine administration and expectation of drug effects in rats. Translational Psychiatry, 2:e175.
Download as PDFDownload as PDF

mGluR7 & addiction: regulation of the receptors and functions in the diffrent phases of addiction (acquisition, expression, maintenance, relapse)

mGluR7 et addiction : régulation des récepteurs et fonctions dans les différentes phases de la dépendance (acquisition, expression, extinction, rechute)
Funding country
France
Project starting year
2013
Project ending year
2018
Area(s) of research
Treatment responses, Consequences of drug use, Mechanism of drug use and effects
Objectives
In collaboration with a chemistry team (F. Acher's group, Pharmacochemistry of alpha-amino acids' receptors) we want to investigate selectively the role of the mGluR7 receptor in addiction (opiates and cocaine), using original and selective chemical structures of molecules for this receptor. In this project we will develop in cellulo and in vivo approaches to answer several questions: 1) Considering therapies, these chemical molecules are to be used repeatedly. It is therefore essential to understand how the mGluR7 are regulated. On a cellular model expressing the mGluR7 we will study the phenomena of internalisation and receptor phosphorylation and desensitisation of different signaling pathways (PKA and PLC), with both allosteric and orthosteric agonists. 2) In vivo, we will study the consequences of administrating selective agonists mGluR7, and conversely the injection of siRNA in the model of behavioral sensitization and conditioned place preference (in a second phase we may also study the impact of these treatments on self-administration models). 3) Using intracerebral microdialysis, we will also study the glutamate/GABA balance in the nucleus accumbens in these various behavioural patterns.
Scientific discipline(s) involved
Neurosciences, Pharmacology
Read more…
Objectives (native)
En collaboration avec une équipe de Chimie (groupe de F. Acher, Pharmacochimie des récepteurs des alpha-aminoacides) nous souhaitons étudier sélectivement le rôle du récepteur mGluR7 dans la dépendance (aux opiacés et à la cocaïne), en utilisant des molécules de structures chimiques originales et sélectives de ce récepteur. Dans ce projet nous mettrons en place des approches in cellulo et in vivo pour répondre à plusieurs questions : 1) Si nous parlons de thérapies, ces molécules chimiques devront être utilisées de façon répétée. Il est donc essentiel de comprendre comment les mGluR7 sont régulés. Sur un modèle cellulaire exprimant le mGluR7 nous étudierons les phénomènes d'internalisation et de phosphorylation du récepteur, et de la désensibilisation des différentes voies de signalisation (PKA et PLC), aussi bien avec des agonistes allostériques que orthostériques. 2) In vivo, nous étudierons les conséquences de l'administration des agonistes sélectifs mGluR7, et inversement de l'injection de siRNA dans le modèle de la sensibilisation comportementale et de la préférence de place conditionnée (dans un second temps on pourra aussi étudier l'impact de ces traitements sur des modèles d'auto-administration). 3) Par microdialyse intracérébrale, nous étudierons également les balances glutamate/GABA dans le noyau accumbens dans ces différents modèles comportementaux.
Initial identified needs
All data from the literature clearly show the important role played by glutamate in all stages of addiction (acquisition, expression, maintenance, relapse). There are two major types of glutamate receptors, ionotropic and metabotropic receptors, the latter having mainly a function in the modulation of neurotransmission. Eight subtypes of metabotropic receptors have been cloned, classified into 3 groups. Data in the literature show that blocking mGluR5 (group I) or activating presynaptic mGluR2/3 receptors (group II) can block the reinforcing effects of different drugs. But very few studies have focused on the group III receptors, which are able to modulate neurotransmitter release by acting as presynaptic auto-receptors , by homo-or hetero-synaptic routes. These receptors can inhibit as well as facilitate the release of glutamate and GABA (but not dopamine) via multiple signaling pathways. In this group we find in particular one of the most abundant receptors in the mesocorticolimbic system, the mGluR7 receptor, which is highly retained between species. This receptor is predominantly localised on the pre-synaptic level. It could therefore be a very interesting therapeutic target. Some studies in the literature point in this direction, but were made with non-selective molecules.
Initial identified needs (native)
L’ensemble des données de la littérature montre sans ambiguïté le rôle primordial joué par le glutamate dans toutes les étapes de la dépendance (acquisition, expression, maintien, rechute). Il y deux grands types de récepteurs au glutamate, les récepteurs ionotropiques et les métabotropiques, ces derniers ayant principalement une fonction de modulation de la neurotransmission. Huit sous types de récepteurs métabotropiques ont été clonés, classés en 3 groupes. Plusieurs données dans la littérature montrent que le blocage des mGluR5 (groupe I) ou l’activation présynaptique des récepteurs mGluR2/3 (groupe II) est capable de bloquer les effets renforçants de différentes drogues. Par contre très peu d’études se sont intéressées aux récepteurs du groupe III, qui sont capables de moduler la libération de neurotransmetteur en agissant comme auto-récepteurs pré-synaptiques de manière homo ou hétéro-synaptique. Ces récepteurs peuvent aussi bien faciliter que inhiber la libération de glutamate et GABA (mais pas de dopamine) via de multiples voies de signalisation. Dans ce groupe on trouve en particulier un des récepteurs les plus abondants dans le système mésocorticolimbique, le récepteur mGluR7, qui est très conservé entre les espèces. Ce récepteur est majoritairement localisé au niveau pré-synaptique. Il pourrait donc présenter une cible thérapeutique très intéressante. Quelques études dans la littérature vont dans ce sens, mais ont été réalisées avec des molécules non sélectives.
Performed by
CNRS - Neuroplasticité et traitements des addictions
CNRS - Pharmacochimie des récepteurs des alpha-aminoacides
Funded by
CNRS
Summary references
Website
non
Published reference(s)
Download as PDFDownload as PDF

Common data collection on drug users addressing addiction addiction treatments centres for substance abuse (RECAP) for 2010-2012

Funding country
France
Project starting year
2010
Project ending year
-
Area(s) of research
Treatment responses
Objectives
To track the number, the characteristics and the patterns of use of legal and illegal drug users seen in the addiction treatments centres for substance abuse, at both a regional and national level in France. To contribute to harmonise data collections targeting the problematic drug users both at the national level and at the European level. To offer to the addiction treatment centres a core of common questions to use to be directed to patients by all staff operating in the drug addiction field.
Scientific discipline(s) involved
History
Read more…
Objectives (native)
- to track the number, the characteristics and the patterns of use of legal and illegal drug users seen in the addiction treatments centres for substance abuse, at both a regional and national level in France. - to contribute to harmonise data collections targeting the problematic drug users both at the national level and at the European level. - to offer to the addiction treatment centres a core of common questions to use to be directed to patients by all staff operating in the drug addiction field.
Initial identified needs
Drug treatment demand is a key indicator collected by the REITOX network under the coordination of the European Centre on Drug and Drug Addiction (EMCDDA). Since 2005, the OFDT has organised a nation-wide data collection from the addiction treatments centres for substance abuse about the patients they’ve received each year. The data collection design exploited in the RECAP questionnaire meets the requirements of the European protocol for the recording of drug treatment demands, defined in the second mid 1990s by the REITOX (European network for the information on Drug Addiction).The definition of a minimum core of questions and indicators has been agreed by a workgroup which gathered drug treatment practitioners and representatives from the concerned administrations and agencies, under the coordination of the OFDT.
Performed by
OFDT (French Monitoring Centre on Drugs and Drug Addictions) - Unit of Indicators
Funded by
OFDT (French Monitoring Centre on Drugs and Drug Addictions)
Summary references
http://www.ofdt.fr/BDD_len/Bd_stats/58_Doc.xhtml
Website
http://www.ofdt.fr/BDD_len/Bd_stats/58_Doc.xhtml
Published reference(s)
BEN LAKHDAR, C. & BASTIANIC, T. (2011) Economic constraint and modes of consumption of addictive goods. International Journal of Drug Policy, 22, 360-365. http://www.ofdt.fr/ofdtdev/live/donneesnat/recap.htmlhttp://odicer.ofdt.fr/#v=map9;i=escapad.ca_canvie_f;l=fr;s=2011
Download as PDFDownload as PDF

Does repression have a gender? Criminal justice for drug-using and drug-trafficking women

Le sexe de la répression. Le traitement pénal des femmes usagères et trafiquantes de drogues
Funding country
France
Project starting year
2011
Project ending year
-
Area(s) of research
Treatment responses, Law enforcement responses, Drug related crime responses
Objectives
To test the impact of gender and the social representations of femininity and masculinity on the decision-making process in the police and judicial service regarding drug-related offences. In this aim, the research is not focused on the only dimension of gender: it integrates this dimension in a theoretical and analytical framework, which is traditionally centred around the social class, ethnicity or criminal record variables, including organisational and contextual variables.
Scientific discipline(s) involved
Sociology
Read more…
Objectives (native)
Tester l'effet de l'appartenance de sexe et des représentations sociales du féminin et du masculin sur le processus décisionnel policier et judiciaire en matière d'infractions à la législation sur les stupéfiants, et ce, non pas en se focalisant exclusivement sur cette dimension du genre mais bien en intégrant celle-ci à un cadre théorique et analytique traditionnellement articulé autour des variables de classe, d'ethnicité, d'antécédents judiciaires ou encore des variables organisationnelles et contextuelles.
Initial identified needs
The gender issue is almost evaded in the sociology of criminal justice in France; The link between gender and the activties of the law-enforcement agents has been seldom studied in French sociology.
Initial identified needs (native)
Quasi absence de la question du genre en sociologie pénale/de la déviance en France; Question de l'effet de l'appartenance de sexe sur l'activité policière et judiciaire très peu traitée en sociologie française.
Performed by
CESDIP (Centre for Sociological Researches on the Law and the Penal Institutions) -UVSQ (Saint-Quentin University)
Funded by
Institut Emilie du Châtelet (DIM "GID"/ Région IDF)
Summary references
Website
oui. http://www.institutemilieduchatelet.org/allocations-doctorales-2011
Published reference(s)
Download as PDFDownload as PDF

ENa-Caarud (National survey in low threshold services for drug users (CAARUD))

Funding country
France
Project starting year
2010
Project ending year
-
Area(s) of research
Prevalence, incidence and patterns of drug use, Treatment responses, Harm reduction responses, Consequences of drug use
Objectives
To assess the characteristics and the practices of the drug users who are received by the CAARUD or reached by their outreach teams. To monitor the trends in relation to drug consumption and to contribute to the detection of emerging drug related phenomena.
Scientific discipline(s) involved
History, Sociology
Read more…
Objectives (native)
- To assess the characteristics and the practices of the drug users who are received by the CAARUD or reached by their outreach teams. - To monitor the trends in relation to drug consumption and to contribute to the detection of emerging drug related phenomena.
Initial identified needs
In France, the CAARUD, i.e. the low threshold services for drug users, provide for risk reduction services. They mainly receive drug users who, whether followed or not by the general or the addictology healthcare system, have generally less controlled drug uses and more precarious social situations than the whole population of drug addicts. With the view of better adjusting the responses directed by professionals and public authorities to this higher risk group, in respect to their changing needs, the French Directorate General for Health has introduced, by the circular of January 2nd, 2006, the implementation of a biennial national survey in low threshold services, entitled “ENa-CAARUD. The first two editions were carried out in 2006 and 2008.
Performed by
OFDT (French Monitoring Centre on Drugs and Drug Addictions) - Unit of Emerging trends
Funded by
OFDT (French Monitoring Centre on Drugs and Drug Addictions)
Summary references
http://www.ofdt.fr/BDD_len/Bd_stats/80_Doc.xhtml
Website
http://www.ofdt.fr/BDD_len/Bd_stats/80_Doc.xhtml
Published reference(s)
CADET-TAÏROU, A. (2012) Résultats ENa-CAARUD 2010. Profils et pratiques des usagers. Saint-Denis, OFDT. CADET-TAÏROU, A., GANDILHON, M. & LAHAIE, E. (2012) Phénomènes marquants et émergents en matière de drogues illicites (2010-2011). Tendances, 1-6. CANARELLI, T. (2011) Détournement des sulfates de morphine : données récentes issues du dispositif TREND de l'OFDT. SWAPS, 64, 5.
Although every reasonable effort is made to present accurate information, ERANID makes no guarantees of any kind and cannot be held liable for any incorrect information or external hyperlinks.

ERANID

Direct access to: